Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Accumulated Expenses (2023 - 2025)

Eton Pharmaceuticals' Other Accumulated Expenses history spans 3 years, with the latest figure at $675000.0 for Q1 2025.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $675000.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $675000.0, a N/A change, with the full-year FY2023 number at $5.4 million, changed N/A from a year prior.
  • Other Accumulated Expenses hit $675000.0 in Q1 2025 for Eton Pharmaceuticals, down from $4.9 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for ETON hit a ceiling of $5.4 million in Q4 2023 and a floor of $675000.0 in Q1 2025.
  • Historically, Other Accumulated Expenses has averaged $3.6 million across 3 years, with a median of $4.9 million in 2024.